Bikanta is a seed startup. 1 investor tracked. Status: possibledead.
Bikanta is a startup founded in 2015 based in the United States. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Bikanta is a biotechnology company that is developing a platform technology for targeted drug delivery. The company's technology is based on a novel class of molecules that can be engineered to bind to specific cells or tissues in the body. Once bound, these molecules can deliver drugs directly to the target site, reducing side effects and improving efficacy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.